Immediate effects of chlorpromazine and perphenazine following neuroleptic washout on word association of schizophrenic patients

Schizophrenia Research

Volumn 26, Issue 1, 1997, Pages 55-63

  Levine, Joseph ^a   Caspi, Nathan ^b   Laufer, Neil ^b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antipsychotic medication; Idiosyncrasy; Reaction time; Schizophrenia; Word associations

Indexed keywords

CHLORPROMAZINE; PERPHENAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; PERSONALITY TEST; PRIORITY JOURNAL; REACTION TIME; SCHIZOPHRENIA;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CHLORPROMAZINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL PROCESSES; MIDDLE AGED; PERPHENAZINE; REACTION TIME; SCHIZOPHRENIA; SCHIZOPHRENIC LANGUAGE; SCHIZOPHRENIC PSYCHOLOGY; VERBAL BEHAVIOR; WORD ASSOCIATION TESTS;

EID: 0030866234     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(97)00034-0     Document Type: Article

References (52)

1. Barrett, S.E., Rugg, M.D., 1989. Event-related potentials and the semantic matching of faces. Neuropsychologia 27, 913-922.
2. Bender, W., Vaital, P., 1985. Cognitive disorders in schizophrenic patients. A controlled study. Eur. Arch. Psychiatry Neurol. Sci. 235, 97-101.
3. Bleuler, F., 1950. Dementia praecox on the group of schizophrenias. Translated by Zinhair, J. International Universities Press, New York.
4. Braff, D., 1993. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 19, 233-259.
5. Braff, D., Saccuzzo, D., 1981. Information processing dysfunction in paranoid schizophrenia: A two factor deficit. Am. J. Psychiatry 138, 1051-1056.
6. Braff, D., Saccuzzo, D., 1982. Effect of anti-psychotic medication on speed of information processing in schizophrenia. Am. J. Psychiatry 139, 1127-1130.
7. Breznitz, S., Ben-David, G., 1991. Dictionary of Hebrew Words Association Norms. Haifa University Press, Haifa, Israel.
8. Calvert, J.E., Babiker, I.E., Harris, J.P., Phillipson, O.T., Ford, M.F., Anteb, D.L., 1990. Object name selection in psychiatric patients before and after neuroleptic therapy. J. Psychopharmacol. 4, 75-82.
9. Cassens, G., Inglis, A.K., Appelbaum, P.S., Gutheil, T.G., 1990. Neuroleptics: effect on neuropsychological function in chronic schizophrenic patients. Schizophr. Bull. 16, 477-499.
10. Chapin, K., Vann, L.E., Lycaki, K., Josef, N., Meyendorff, E., 1989. Investigation of the associative network in schizophrenia using the semantic priming paradigm. Schizophr. Res. 2, 355-360.
11. Chen, E.Y., Wilkins, A.J., McKenna, P.J., 1994. Semantic memory is both impaired and anomalous in schizophrenia. Psychol. Med. 24, 193-202.
12. Classen, W., Laux, G., 1988. Sensorimotor and cognitive performance of schizophrenic patients treated with haloperidol, flupenthixol, or clozapine. Pharmacopsychiatry 21, 295-297.
13. Davidson, M.D., Kahn, R.S., Powchik, P., Warne, P., Losonczy, M.F., Kaminsky, R., Apter, S., Jaff, S., Davis, K.L., 1991. Changes in plasma HVA concentration in schizophrenic patients following neuroleptic discontinuation. Arch. Gen. Psychiatry 48, 73-76.
14. DiMascio, A., Havens, L.L., 1963. The psychopharmacology of the effects of chlorpromazine, promethazine, trifluoperazine and perphenazine in normal males. II Results and discussion. J. Nerv. Ment. Dis. 136, 168-186.
15. Garner, D.M., Garfinkel, P.E., Bemis, K.M., 1982. A multidimensional psychotherapy for anorexia nervosa. Int. J. Eating Disorders 1, 3-46.
16. Gilbert, P.L., Harris, M.J., McAdams, L.A., Jeste, D.V., 1995. Neuroleptic withdrawal in schizophrenic patients. Review of the literature. Arch. Gen. Psychiatry 52, 173-188.
17. Goff, D.C., Tsai, G., Manoach, D.S., Coyle, J.T., 1995. Dose finding trial of D-cycloserine added to neuroleptics for negative symptoms in schizophrenia. Am. J. Psychiat. 152, 1213-1215.
18. Goldberg, T.E., Weinberger, D.R., Berman, K.F., Pliskin, N.H., Podd, M.H., 1987. Further evidence for dementia of the prefrontal type in schizophrenia? Arch. Gen. Psychiatry 44, 1008-1014.
19. Goldberg, T.E., Weinberger, D.R., 1994. The effects of clozapine on neurocognition. An overview.. J. Clin. Psychiatry 55, 9 (Suppl. B), 80-90.
20. Hagger, C., Buckley, P., Kenny, J.T., Friedman, L., Ubogy, D., Meltzer, H.Y., 1993. Improvement in cognitive functions and psychiatric symptoms in treatment - refractory schizophrenic patients receiving clozapine. Biol. Psychiatry 34, 702-712.
21. Hoffman, R.E., McGlashan, T., 1993. Parallel distributed processing and the emergence of schizophrenic symptoms. Shizophr. Bull. 19, 119-140.
22. Jung, K., 1981. Reaction time ratio in the association experiment. In: Read, H., Fordnam, M., Adler, G. (Eds.), The Collected Works of C.G. Jung. Princeton University Press, Princeton, NJ, pp. 227-265.
23. Kenny, J.T., Meltzer, H.Y., 1991. Attention and higher cortical functions in schizophrenia. J. Neuropsychiatry Clin. Neurosci. 3, 269-275.
24. King, D.J., 1990. The effect of neuroleptics on cognitive and psychomotor function. Br. J. Psychiatry 157, 799-811.
25. Kornetsky, C., Humphries, O., Evarts, E.V., 1957. Comparison of psychological effects of certain centrally acting drugs in man. AMA Arch. Neurol. Psychiatry 77, 318-324.
26. Kornetsky, C., Pettit, M., Wynne, R., 1959. A comparison of the psychological effects of acute and chronic administration of chlorpromazine and secobarbital (quinalbarbitone) in schizophrenic patients. J. Mental Sci. 105, 190-198.
27. Lee, M.A., Thompson, P.A., Meltzer, H.Y., 1994. Effects of clozapine on cognitive functions in schizophrenia. J. Clin. Psychiatry 55, 9 (Suppl B), 82-90.
28. Lehmann, H.E., Hanrahan, G.E., 1954. Chlorpromazine. New inhibiting agent for psychomotor excitement and manic states. AMA Arch. Neurol. Psychiatry 71, 227-237.
29. Lehmann, H., Cancro, R., Weiner, H., 1989. Schizophrenia: Psychopharmacological treatments. In: Karasu, T.B. (Ed.), Treatments of Psychiatric Disorders, APA Press, Washington, D.C., Vol. 2, pp. 1501-1541.
30. Medalia, A., Gold, J., Merriam, A., 1988. The effect of neuroleptics on neuro-psychological test results of schizophrenics. Arch. Clin. Neuropsychol. 3, 249-271.
31. Meltzer, H.Y., 1992. Dimensions of outcome with clozapine. Br. J. Psychiatry 160 (Suppl), S43-S53.
32. Moskowitz, J., Davidson, M., Harvey, P.D., 1991. Effect of concurrent distraction on communication failures in schizophrenic patients II. Medication status correlations. Schizophr. Res. 5, 153-159.
33. Nuechterlein, K., Dawson, M., 1984. Information processing and attentional functioning in the development course of schizophrenic disorder. Schizophr. Bull. 10, 160-203.
34. O'Brian, J.P., Weingartner, H., 1970. Associative structure in chronic schizophrenia. Arch. Gen. Psychiatry 22, 136-142.
35. Penn, D.L., Muser, K.T., Spaulding, W., Hope, D.A., Reed, D., 1995. Information processing and social competence in chronic schizophrenia. Schizophr. Bull. 21, 269-281.
36. Pickar, D., 1988. Perspectives on a time dependent model of neuroleptic action. Schizophr. Bull. 114, 255-258.
37. Pickar, D., Labarca, R., Doran, A.R., Wolkowitz, O.M., Roy, A., Breier, A., Linnoila, M., Paul, S.M., 1986. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Correlation with psychosis and response to neuroleptic treatment. Arch. Gen. Psychiatry 43, 669-676.
38. Plisken, N., Raz, N., Raz, S., Weinberger, D.R., 1987. Neuroleptic withdrawal and deterioration of verbal fluency in schizophrenia: A preliminary report. J. Clin. Exp. Neuropsychol. 9, 62
39. Rupniak, N.M., Kilpatrick, G., Hall, M.D., Jenner, P., Marsden, C.D., 1984. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats. Psychopharmacology 84, 512-519.
40. Saarma, J., Saarma, M., Sild, L., Tikk, P., 1974. Effect of thiothixene upon the higher nervous activity in chronic schizophrenics. Int. Pharmacopsychiatry 9, 109-117.
41. Saletu, B., Kufferle, B., Granberger, J., Anderer, P., 1986. Quantitative EEG, SPEM and psychometric studies in schizophrenics before and during differential neuroleptic therapy. Pharmacopsychiatry 19, 434-437.
42. Saykin, A.J., Gur, R.C., Gur, R.E., 1991. Neuropsychological function in schizophrenia: Selective impairment in memory and learning. Arch. Gen. Psychiatry 48, 618-624.
43. Schwartz, S., 1978. Do schizophrenics give rare word associations? Schizophr. Bull. 4, 248-251.
44. Seidman, L.J., 1983. Schizophrenic and brain dysfunction: An integration of recent neurodiagnostic findings. Psychol. Bull. 94, 195-248.
45. Serafetinides, E.A., Clark, M.L., 1973. Psychological effects of single-dose antipsychotic medication. Biol. Psychiatry 7, 263-267.
46. Serper, M.R., Bergman, R.L., Harvey, P.D., 1990. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res. 32, 281-288.
47. Serper, M.R., Davidson, M., Harvey, P.D., 1994. Attentional predictors of clinical change during neuroleptic treatment in schizophrenia. Schizophr. Res. 13, 65-71.
48. Shakow, D., 1980. Kent-Rosanoff association and its implications for segmental set theory. Schizophr. Bull. 6, 676-685.
49. Shaw, E.D., John Mann, J., Stokes, P.E., Manevitz, A.Z.A., 1986. Effects of lithium carbonate on associative productivity and idiosyncrasy in bipolar outpatients. Am. J. Psychiatry 143, 1166-1169.
50. Spohn, H.E., Strauss, M.E., 1989. Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophrenia. J. Abnorm. Psychol. 98, 367-380.
51. Viguera, A.C., Baldessarini, R.J., van Kammen, D., Suppes, T., 1995. Clinical survival following discontinuation of maintenance treatment with oral or long-acting, injected neuroleptic or lithium. In: Proceedings of the Annual Meeting of the American Psychiatric Association, Miami, FL.
52. Wahba, M., Donlon, P., Meadow, A., 1980. Cognitive changes in acute schizophrenia with brief neuroleptic treatment. Am. J. Psychiatry 138, 1307-1310.